Medifast (MED) Short-term Investments (2010 - 2026)

Medifast has reported Short-term Investments for 17 years, with the latest figure at $97.4 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments rose 33.68% year-over-year to $97.4 million; the trailing twelve-month figure through Mar 2026 stood at $97.4 million (up 33.68% YoY), and the FY2025 full-year result was $78.0 million, up 9.18% from the prior year.
• Short-term Investments for Q1 2026 stood at $97.4 million, up from $78.0 million in the prior quarter.
• The five-year high for Short-term Investments was $97.4 million in Q1 2026, with the low at $4.1 million in Q1 2022.
• Historically, Short-term Investments has averaged $60.7 million across 5 years, with a median of $60.0 million in 2024.
• Annual changes were most pronounced in 2022 — Short-term Investments tumbled 41.06% — and 2025, when it jumped 35.39%.
• Medifast's Short-term Investments stood at $4.1 million in 2022, then surged by 1270.5% to $55.6 million in 2023, then grew by 28.44% to $71.4 million in 2024, then increased by 9.18% to $78.0 million in 2025, then climbed by 24.94% to $97.4 million in 2026.
• The last three Short-term Investments figures came in at $97.4 million (Q1 2026), $78.0 million (Q4 2025), and $74.0 million (Q3 2025), per Business Quant data.